BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9920377)

  • 1. Radioiodine therapy and Graves' ophthalmopathy.
    Spitzweg C; Rossmüller B; Heufelder AE
    Thyroid; 1998 Dec; 8(12):1193. PubMed ID: 9920377
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA
    Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
    Salvatore D; Fenzi G
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
    Pinchera A; Bartalena L; Marcocci C
    J Clin Endocrinol Metab; 1995 Feb; 80(2):342-5. PubMed ID: 7852486
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
    Gorman CA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
    Rosetti S; Tanda ML; Veronesi G; Masiello E; Premoli P; Gallo D; Cusini C; Donati S; Sabatino J; Ippolito S; Piantanida E; Bartalena L
    J Endocrinol Invest; 2020 Mar; 43(3):381-383. PubMed ID: 31587179
    [No Abstract]   [Full Text] [Related]  

  • 10. Does radioiodine cause the ophthalmopathy of Graves' disease?
    McDougall IR
    Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
    Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the effects of radioiodine therapy on Graves' ophthalmopthy.
    Bartalena L; Marcocci C; Pinchera A
    Thyroid; 1998 Jun; 8(6):533-4. PubMed ID: 9669292
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
    Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
    Barth A; Probst P; Bürgi H
    J Endocrinol Invest; 1991 Mar; 14(3):209-12. PubMed ID: 2071823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy and Graves' ophthalmopathy.
    Bartalena L
    Nucl Med Commun; 2002 Nov; 23(11):1143-5. PubMed ID: 12411845
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
    Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
    Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy in Graves' disease: is it possible to predict outcome before therapy?
    Isgoren S; Daglioz Gorur G; Demir H; Berk F
    Nucl Med Commun; 2012 Aug; 33(8):859-63. PubMed ID: 22669051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine and Graves' ophthalmopathy reconsidered.
    Noury AM; Stanford MR; Graham EM
    Nucl Med Commun; 2001 Nov; 22(11):1167-9. PubMed ID: 11606880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.